PublicacionesPublicaciones científicas y comunicaciones a congresos. Publicaciones científicas Comunicaciones a congresos ESMO ASCO Alberto Carral Maseda Marta Covela Rúa Sergio Vazquez-Estevez Jesús Mateos Martín Begoña Campos Balea Francisco Javier Casas Nebra Outcomes and patterns of use of Radium-223 in metastatic castration-resistant prostate cancerJul 14, 2025 | Francisco Javier Casas Nebra, Publicaciones científicas, Sergio Vazquez-EstevezExploring the exoproteome of the parasitic nematode Anisakis simplex (s. s.) and its impact on the human host – an in vitro cross-talk proteomic approachFeb 3, 2025 | Jesús Mateos Martín, Publicaciones científicasZenoSWATH DIA proteomics and clustering analysis of the effect of cysteamine at the cellular level in cystinotic fibroblastsNov 6, 2024 | Jesús Mateos Martín, Publicaciones científicasPotential Prognostic Protein Biomarkers in Tears From Noninfectious Uveitis Patients Under Biologic Treatment as a Prelude to Personalized MedicineNov 4, 2024 | Jesús Mateos MartínAcceptance and results of cryoablation for the treatment of early breast cancer in non-surgical patientsOct 1, 2024 | Ignacio Fernández Sobrado, Publicaciones científicas914P The landscape of somatic copy number alterations of head and neck squamous cell carcinoma across different anatomic sitesSep 17, 2024 | Alberto Carral Maseda, Comunicaciones a congresos, ESMORecommendations from the Galician Oncological Society and the Galician Society of Nuclear Medicine for the use of 177Lu-PSMA-617 radioligand-therapy in prostate cancerSep 12, 2024 | Francisco Javier Casas Nebra, Publicaciones científicas, Sergio Vazquez-EstevezPreclinical characterization of endotoxin-induced uveitis models using OCT, PET/CT and proteomicsSep 5, 2024 | Jesús Mateos Martín, Publicaciones científicas871P Randomized phase II trial of nivolumab plus paclitaxel in subjects with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) unable for cisplatin (CP)-based chemotherapy (CT): NIVOTAX TTCC studySep 2, 2024 | Comunicaciones a congresos, ESMOReal-world dosing patterns of regorafenib for patients with metastatic colorectal cancer in Spain: the RE-SEARCH studyAgo 11, 2024 | Alberto Carral Maseda, Publicaciones científicas « Entradas Anteriores
Outcomes and patterns of use of Radium-223 in metastatic castration-resistant prostate cancerJul 14, 2025 | Francisco Javier Casas Nebra, Publicaciones científicas, Sergio Vazquez-Estevez
Exploring the exoproteome of the parasitic nematode Anisakis simplex (s. s.) and its impact on the human host – an in vitro cross-talk proteomic approachFeb 3, 2025 | Jesús Mateos Martín, Publicaciones científicas
ZenoSWATH DIA proteomics and clustering analysis of the effect of cysteamine at the cellular level in cystinotic fibroblastsNov 6, 2024 | Jesús Mateos Martín, Publicaciones científicas
Potential Prognostic Protein Biomarkers in Tears From Noninfectious Uveitis Patients Under Biologic Treatment as a Prelude to Personalized MedicineNov 4, 2024 | Jesús Mateos Martín
Acceptance and results of cryoablation for the treatment of early breast cancer in non-surgical patientsOct 1, 2024 | Ignacio Fernández Sobrado, Publicaciones científicas
914P The landscape of somatic copy number alterations of head and neck squamous cell carcinoma across different anatomic sitesSep 17, 2024 | Alberto Carral Maseda, Comunicaciones a congresos, ESMO
Recommendations from the Galician Oncological Society and the Galician Society of Nuclear Medicine for the use of 177Lu-PSMA-617 radioligand-therapy in prostate cancerSep 12, 2024 | Francisco Javier Casas Nebra, Publicaciones científicas, Sergio Vazquez-Estevez
Preclinical characterization of endotoxin-induced uveitis models using OCT, PET/CT and proteomicsSep 5, 2024 | Jesús Mateos Martín, Publicaciones científicas
871P Randomized phase II trial of nivolumab plus paclitaxel in subjects with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) unable for cisplatin (CP)-based chemotherapy (CT): NIVOTAX TTCC studySep 2, 2024 | Comunicaciones a congresos, ESMO
Real-world dosing patterns of regorafenib for patients with metastatic colorectal cancer in Spain: the RE-SEARCH studyAgo 11, 2024 | Alberto Carral Maseda, Publicaciones científicas
